Structure based on 4xs2 |
Ideal structure |
|
| Name: (1r,2s,3r,5r)-3-({5-(1,3-benzothiazol-2-yl)-6-chloro-2-[(3-methoxypropyl)amino]pyrimidin-4-yl}amino)-5-(hydroxymethyl)cyclopentane-1,2-diol |
| Formula: C21 H26 Cl N5 O4 S |
| Weight: 479.980 |
| SMILES: "COCCCNc1nc(Cl)c(c(N[CH]2C[CH](CO)[CH](O)[CH]2O)n1)c3sc4ccccc4n3" |
| Spacial conformation based on PDB
4xs2 |
RESIDUE 42P 58
CONECT C01 3 N02 C06 N07
CONECT N02 2 C01 C03
CONECT C03 3 N02 N04 N08
CONECT N04 2 C03 C05
CONECT C05 3 N04 C06 CL9
CONECT C06 3 C01 C05 C10
CONECT N07 3 C01 C11 H1
CONECT N08 3 C03 C20 H2
CONECT CL9 1 C05
CONECT C10 3 C06 S25 N28
CONECT C11 4 N07 C12 C15 H3
CONECT C12 4 C11 C13 O16 H4
CONECT C13 4 C12 C14 O17 H5
CONECT C14 4 C13 C15 C18 H6
CONECT C15 4 C11 C14 H7 H8
CONECT O16 2 C12 H9
CONECT O17 2 C13 H10
CONECT C18 4 C14 O19 H11 H12
CONECT O19 2 C18 H13
CONECT C20 4 N08 C21 H14 H15
CONECT C21 4 C20 C22 H16 H17
CONECT C22 4 C21 O23 H18 H19
CONECT O23 2 C22 C24
CONECT C24 4 O23 H20 H21 H22
CONECT S25 2 C10 C26
CONECT C26 3 S25 C27 C29
CONECT C27 3 C26 N28 C32
CONECT N28 2 C10 C27
CONECT C29 3 C26 C30 H23
CONECT C30 3 C29 C31 H24
CONECT C31 3 C30 C32 H25
CONECT C32 3 C27 C31 H26
CONECT H1 1 N07
CONECT H2 1 N08
CONECT H3 1 C11
CONECT H4 1 C12
CONECT H5 1 C13
CONECT H6 1 C14
CONECT H7 1 C15
CONECT H8 1 C15
CONECT H9 1 O16
CONECT H10 1 O17
CONECT H11 1 C18
CONECT H12 1 C18
CONECT H13 1 O19
CONECT H14 1 C20
CONECT H15 1 C20
CONECT H16 1 C21
CONECT H17 1 C21
CONECT H18 1 C22
CONECT H19 1 C22
CONECT H20 1 C24
CONECT H21 1 C24
CONECT H22 1 C24
CONECT H23 1 C29
CONECT H24 1 C30
CONECT H25 1 C31
CONECT H26 1 C32
END
HET 42P 58
HETNAM 42P (1R,2S,3R,5R)-3-({5-(1,3-benzothiazol-2-yl)-6-chloro-2-
HETNAM 2 42P [(3-methoxypropyl)amino]pyrimidin-4-yl}amino)-5-(hydrox
HETNAM 3 42P ymethyl)cyclopentane-1,2-diol
FORMUL 42P C21 H26 Cl1 N5 O4 S1
MONOMER page